Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £860.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Directorate Change

18 Jul 2019 07:00

RNS Number : 9024F
Oakley Capital Investments Limited
18 July 2019
 

18 July 2019

Oakley Capital Investments Limited

Board Changes

Oakley Capital Investments Limited1 (AIM:OCI; the "Company" or "OCI") is pleased to announce the appointment of a new independent Non-Executive Director to its Board, Mr Craig Bodenstab, with immediate effect. Mr Bodenstab, a qualified accountant and CFA charterholder, brings a wealth of experience in finance and fund management to the Board.

Alongside the appointment of Mr Bodenstab, Mr James Keyes will step down from the Board with immediate effect. Mr Keyes has decided to retire from his role on the Board after many years' service.

Caroline Foulger, Chair of Oakley Capital Investments Limited, said:

"I would like to thank James for his significant contribution during his time as Director, a tenure that has overseen the substantial growth and development of OCI."

"We are excited to welcome Craig Bodenstab to the Board. Craig brings significant knowledge and expertise from a long career in investment management and having served on investment company boards. We look forward to benefiting from his considerable experience as he joins us as a Board member."

Biography of Craig Bodenstab

Craig Bodenstab is a recently retired Partner and Director of Orbis Investments, a global asset manager with over £27 billion of assets under management, where he held senior executive roles until stepping down in late 2017. Prior to that, Craig was a Partner and Managing Director of Cameron Capital Management, a family office that focused primarily on managing private placements and convertible bonds. He has a Bachelor of Commerce from Dalhousie University and a Master of Business Administration from Columbia University and London Business School. Craig is a qualified accountant and a CFA charterholder. He currently holds directorships in a select number of private investment related companies including some not-for-profit organisations.

Regulatory Disclosures

 

The following disclosures are required regarding Craig Bodenstab's appointment pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

 

Full name and age: Craig Theodor Bodenstab, aged 50.

 

Current Directorships

Former Directorships (within the last 5 years)

Allan Gray Africa ex-SA Equity Fund Ltd

Orbis Investment Management Ltd

Allan Gray Africa Equity Fund Ltd

Orbis Asset Management Ltd

Allan Gray Africa ex-SA Bond Fund Ltd

Allan Gray Bermuda Ltd

Allan Gray Frontier Markets Equity Fund Ltd

Baobab Global Fund Limited

Bermuda Zoological Society

Cederberg Capital (Cayman) Ltd

Windhoek Holdings

No further disclosure is required under AIM Rule 17 or paragraph (g) to Schedule Two of the AIM Rules for Companies with respect to Craig Bodenstab.

- ends-

For further information please contact:

Oakley Capital Investments Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

 

Greenbrook Communications Ltd

+44 20 7952 2000

Alex Jones / Matthew Goodman / Gina Bell

 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Gillian Martin / Owen Matthews

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

1 About Oakley Capital Investments Limited ("OCI")

OCI is an AIM traded investment vehicle, which provides access to the Oakley Funds². It is a liquid vehicle that aims to provide capital growth and dividends to investors.

²The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital III and Oakley Capital IV, are unlisted focused mid-market private equity funds with the aim of providing investors with significant long-term capital appreciation. The investment strategy of the funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

The Investment Adviser

Founded in 2002, Oakley Capital has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this they rely on their sector and regional expertise, their ability to tackle transaction complexity and their deal generating entrepreneur network.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKMGMNZNZGLZZ
Date   Source Headline
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20264:51 pmRNSResult of AGM
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSOakley Capital invests in XTEL
21st May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of AGM
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTrading update for the 3 months ended 31 March 26
24th Apr 20267:00 amRNSDirector Dealing
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSStandard form for notification of major holdings
17th Mar 20267:00 amRNSOakley Capital partners with Groupe Senef
17th Mar 20267:00 amRNSOakley Capital partners with Groupe Senef
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
12th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
10th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSNotice of Results and Investor Presentation
3rd Mar 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSDirector Dealing
17th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 202612:05 pmRNS-RUpdate from QuotedData
11th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20269:43 amRNS-RUpdate from QuotedData
4th Feb 20267:00 amRNSDirector Dealing
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading update for the year ended 31 December 2025
26th Jan 20267:00 amRNSStandard form for notification of major holdings
9th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20265:49 pmRNSStandard form for notification of major holdings
5th Jan 20267:00 amRNSOakley Capital invests in GLAS
5th Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 202511:18 amRNSStandard form for notification of major holdings
24th Dec 202511:18 amRNSStandard form for notification of major holdings
24th Dec 202511:04 amRNSTransaction in Own Shares
24th Dec 202511:04 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.